The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – United States December 2020
Oliver, S., Gargano, J., Marin, M., et al..
(2020).
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – United States, December 2020.
(Added 12/30/2020.) Morbidity and Mortality Weekly Report 69(50);1922-1924.
This report documents the rationale supporting ACIP’s interim recommendation to use the Pfizer BioNTech vaccine in persons age 16 and older.
Favorite:
Login to rate, favorite, and comments
on the article
Comments
0
Toggle Open/Close
You must Login to add a comment
- This item doesn't have any comments